110 related articles for article (PubMed ID: 28283460)
1. Anti-Parkinsonian L-Dopa can also act as anti-systemic amyloidosis-A mechanistic exploration.
Nusrat S; Zaidi N; Siddiqi MK; Zaman M; Siddique IA; Ajmal MR; Abdelhameed AS; Khan RH
Int J Biol Macromol; 2017 Jun; 99():630-640. PubMed ID: 28283460
[TBL] [Abstract][Full Text] [Related]
2. Repositioning nordihydroguaiaretic acid as a potent inhibitor of systemic amyloidosis and associated cellular toxicity.
Nusrat S; Zaidi N; Zaman M; Islam S; Ajmal MR; Siddiqi MK; Santra MK; Khan RH
Arch Biochem Biophys; 2016 Dec; 612():78-90. PubMed ID: 27789205
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the enhanced inhibitory, disaggregating and cytoprotective potential of promethazine towards amyloid fibrillation.
Nusrat S; Zaman M; Masroor A; Siddqi MK; Zaidi N; Neelofar K; Abdelhameed AS; Khan RH
Int J Biol Macromol; 2018 Jan; 106():851-863. PubMed ID: 28823512
[TBL] [Abstract][Full Text] [Related]
4. Interaction of catecholamine precursor l-Dopa with lysozyme: A biophysical insight.
Nusrat S; Masroor A; Zaman M; Siddiqi MK; Ajmal MR; Zaidi N; Abdelhameed AS; Khan RH
Int J Biol Macromol; 2018 Apr; 109():1132-1139. PubMed ID: 29157902
[TBL] [Abstract][Full Text] [Related]
5. Investigating the effects of erythrosine B on amyloid fibril formation derived from lysozyme.
Kuo CT; Chen YL; Hsu WT; How SC; Cheng YH; Hsueh SS; Liu HS; Lin TH; Wu JW; Wang SS
Int J Biol Macromol; 2017 May; 98():159-168. PubMed ID: 28137461
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Amyloid Fibrillation of HEWL by 4-Methylcoumarin and 4-Methylthiocoumarin Derivatives.
Kumar S; Kumar M; Tyagi YK; Kumar S
Curr Pharm Biotechnol; 2021; 22(2):232-244. PubMed ID: 32933456
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation.
Khan AN; Nabi F; Khan RH
Biophys Chem; 2023 Jul; 298():107029. PubMed ID: 37150142
[TBL] [Abstract][Full Text] [Related]
8. Investigating the inhibitory effects of entacapone on amyloid fibril formation of human lysozyme.
Jin L; Gao W; Liu C; Zhang N; Mukherjee S; Zhang R; Dong H; Bhunia A; Bednarikova Z; Gazova Z; Liu M; Han J; Siebert HC
Int J Biol Macromol; 2020 Oct; 161():1393-1404. PubMed ID: 32750483
[TBL] [Abstract][Full Text] [Related]
9. Brilliant blue R dye is capable of suppressing amyloid fibril formation of lysozyme.
How SC; Hsu WT; Tseng CP; Lo CH; Chou WL; Wang SS
J Biomol Struct Dyn; 2018 Oct; 36(13):3420-3433. PubMed ID: 28984498
[TBL] [Abstract][Full Text] [Related]
10. Biophysical insight into anti-amyloidogenic nature of novel ionic Co(II)(phen)(H
Masroor A; Zaidi N; Nabi F; Malik S; Zehra S; Arjmand F; Naseem N; Khan RH
Biophys Chem; 2024 May; 308():107214. PubMed ID: 38428228
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the inhibitory potential of natural compound luteolin on human lysozyme fibrillation.
Ali SM; Nabi F; Hisamuddin M; Rizvi I; Ahmad A; Hassan MN; Paul P; Chaari A; Khan RH
Int J Biol Macromol; 2023 Apr; 233():123623. PubMed ID: 36773857
[TBL] [Abstract][Full Text] [Related]
12. Exploring the effects of methylene blue on amyloid fibrillogenesis of lysozyme.
How SC; Cheng YH; Lo CH; Lai JT; Lin TH; Bednarikova Z; Antosova A; Gazova Z; Wu JW; Wang SS
Int J Biol Macromol; 2018 Nov; 119():1059-1067. PubMed ID: 30099040
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel inhibited lysozyme fibrillation by increasing colloidal stability through formation of "off-pathway" oligomers.
Kachooei E; Mozaffarian F; Khodagholi F; Sadeghi P; Karami L; Ghasemi A; Vahdat E; Saboury AA; Sheibani N; Moosavi-Movahedi AA
Int J Biol Macromol; 2018 May; 111():870-879. PubMed ID: 29352977
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and structure-activity relationships of seven manganese-salen derivatives as anti-amyloidogenic and fibril-destabilizing agents against hen egg-white lysozyme aggregation.
Bahramikia S; Yazdanparast R; Gheysarzadeh A
Chem Biol Drug Des; 2012 Aug; 80(2):227-36. PubMed ID: 22530978
[TBL] [Abstract][Full Text] [Related]
15. Exploring the influence of brilliant blue G on amyloid fibril formation of lysozyme.
How SC; Hsin A; Chen GY; Hsu WT; Yang SM; Chou WL; Chou SH; Wang SS
Int J Biol Macromol; 2019 Oct; 138():37-48. PubMed ID: 31295491
[TBL] [Abstract][Full Text] [Related]
16. Oligomers, protofibrils and amyloid fibrils from recombinant human lysozyme (rHL): fibrillation process and cytotoxicity evaluation for ARPE-19 cell line.
Ruiz ED; Almada M; Burboa MG; Taboada P; Mosquera V; Valdez MA; Juárez J
Colloids Surf B Biointerfaces; 2015 Feb; 126():335-43. PubMed ID: 25618793
[TBL] [Abstract][Full Text] [Related]
17. Unravelling the inhibitory and cytoprotective potential of diuretics towards amyloid fibrillation.
Malik S; Siddiqi MK; Majid N; Masroor A; Moasfar Ali S; Khan RH
Int J Biol Macromol; 2020 May; 150():1258-1271. PubMed ID: 31743708
[TBL] [Abstract][Full Text] [Related]
18. Anti-amyloidogenic and fibril-destabilizing effects of two manganese-salen derivatives against hen egg-white lysozyme aggregation.
Bahramikia S; Yazdanparast R
Int J Biol Macromol; 2012 Jan; 50(1):187-97. PubMed ID: 22061184
[TBL] [Abstract][Full Text] [Related]
19. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
[TBL] [Abstract][Full Text] [Related]
20. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
